Transcriptomics analysis revealed that host cellular protein CD24 was present at moderate to high levels in the ZIKV-permissive neuroblastoma cell lines (e.g., IMR-32, CHLA-42, SMS-KAN). This evidence concerns the gene CD24 and neuroblastoma.